<DOC>
	<DOCNO>NCT00557336</DOCNO>
	<brief_summary>This trial conduct Europe . The aim clinical trial evaluate height gain 12 month growth hormone treatment child bear small gestational age due intrauterine growth retardation .</brief_summary>
	<brief_title>Efficacy Safety Growth Hormone Treatment Children Small Gestational Age</brief_title>
	<detailed_description />
	<criteria>Born small gestational age ( SGA ) due intrauterine growth retardation ( IUGR ) define birth length and/or weight P10 Chronological age least 4 year old bone age maturation maximum 12 year girls maximum 13,5 boys time inclusion study Insufficient catchup growth ( height lesser equal 2.5 SDS chronological age Normal response GH stimulation test ( great 10 ng/mL ) Diabetes Growth retardation associate infection severe chronic disease ( include chromosomal anomaly nutritional disorder ) Treatment medical product ( anabolic drug , sex steroid , etc . ) may interfere GH effect History presence severe disease could interfere GH treatment/participation trial , e.g . active malignancy Previous ongoing growth hormone therapy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>